Skip to main content

Table 3 Comparison of medication at discharge between two longitudinal cohorts

From: Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudinal cohort study

Characteristics

Overall population (N=121)

P value

Cohort 1 ( N =35)

Cohort 2 ( N =86)

ACEI/ARB, N (%)

13 (37.1)

48 (55.8)

0.063

Aldactone, N (%)

7 (20.0)

23 (26.7)

0.436

Beta-blocker, N (%)

29 (82.9)

65 (75.6)

0.383

Statin, N (%)

21 (60.0)

48 (55.8)

0.673

Digoxin, N (%)

4 (11.4)

9 (10.5)

1.000

Propafenone, N (%)

1 (2.9)

1 (1.2)

0.497

Cordarone, N (%)

7 (20.0)

29 (33.7)

0.134

  1. ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker